Get it on Google Play

Revvity (RVTY) Secures FDA Approval for Improved Automated Latent Tuberculosis Test

April 2, 2025 8:01 AM UTC Send to a Friend
Revvity, Inc. (NYSE: RVTY), today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login